Treatment of latent tuberculosis infection.
De Rosa
Francesco G
FG
Craven
Donald E
DE
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D014376:Tuberculosis / Q000139:chemically induced / Q000150:complications*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab